Neopharma LLC

Last updated on: 04 October 2019

NeoBiocon Partners with Novartis to offer Vildagliptin for Diabetics in UAE

NeoBiocon, a collaboration between Asia's leading biopharmaceuticals company Biocon Ltd and Dr. B.R. Shetty, Chairman of the UAE-based Neopharma, announced today that it has partnered with Novartis Middle East FZE, to market Jalra (Vildagliptin) and Jalra-M (Vildagliptin + Metformin) in UAE. This partnership will help NeoBiocon expand its product offerings in the

Press Release - 09-Dec-2015

Find Out More Information

Access the most comprehensive database of companies and officers in the Middle East and North Africa, covering all major sectors and industries, from Refinitiv.

LEARN MORE

Company information provided by © 2020 Thomson Reuters

Thomson Reuters research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

Find Companies

most viewed